The legalization and proliferation of an commercially-offered implanted brain chip, especially one that interfaced with the notoriously vital hypothalamus, was met with public outcry and legislative difficulty, to the surprise of no one. However, the surprise over the speed with which that public outcry and legislative difficulty drained away was more than enough to fill the void. First came the reports of the surgery’s success rate. Near perfect under robotic surgery, with complications occuring fast enough that the procedure could easily be abandoned. Relatively cheap to produce, even given the billions that went into its design. A high-end and a low-end version, offering options to the destitute as long as they could tolerate the fatigue that the more expensive option eliminated. A bit of political lower-case-L leverage, and workforces were offering free surgeries to new hires. The medical industry briefly soared, and sleep was all but eliminated in the American workforce, with other industrialized countries soon to come. It seems extreme for the worker, but you can’t honestly expect an employer to hire someone willing to sacrifice an entire shift of extra productivity over a bit of personal discomfort, can you? After all. It’s Only Business. Side Chatter Music Credits Players